Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Tuccori

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Pathogens (Basel, Switzerland)|July 27, 2022
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in ItalyDaniele Focosi, Marco Tuccori
Evidence-Based Mental Health|April 23, 2016
SSRIs and birth defects: can a new statistical approach resolve old controversies?Marco Tuccori, Corrado Blandizzi
Life (Basel, Switzerland)|March 6, 2021
The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19Daniele Focosi, Marco Tuccori, Massimo Franchini
Annals of Translational Medicine|February 5, 2020
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?Daniele Focosi, Marco Tuccori, Fabrizio Maggi
Reviews in Medical Virology|August 2, 2019
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximabDaniele Focosi, Marco Tuccori, Fabrizio Maggi
Minerva Pediatrics|February 18, 2017
Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug AdministrationCaterina Bigi, Marco Tuccori, Guido Bocci
Journal of the National Cancer Institute|December 30, 2015
RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch SyndromeMarco Tuccori, Kristian B Filion, Laurent Azoulay
Expert Opinion on Drug Safety|October 5, 2018
The usefulness of listening social media for pharmacovigilance purposes: a systematic reviewIrma Convertino, Sara Ferraro, Corrado Blandizzi, et al.
Vaccines|January 22, 2022
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic ReviewDaniele Focosi, Massimo Franchini, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Editorial: Traditional and innovative approaches for signal detectionMarco Tuccori, Andrew Bate, Ugo Moretti, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Pathogens (Basel, Switzerland)|July 27, 2022
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in ItalyDaniele Focosi, Marco Tuccori
Evidence-Based Mental Health|April 23, 2016
SSRIs and birth defects: can a new statistical approach resolve old controversies?Marco Tuccori, Corrado Blandizzi
Life (Basel, Switzerland)|March 6, 2021
The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19Daniele Focosi, Marco Tuccori, Massimo Franchini
Annals of Translational Medicine|February 5, 2020
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?Daniele Focosi, Marco Tuccori, Fabrizio Maggi
Reviews in Medical Virology|August 2, 2019
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximabDaniele Focosi, Marco Tuccori, Fabrizio Maggi
Minerva Pediatrics|February 18, 2017
Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug AdministrationCaterina Bigi, Marco Tuccori, Guido Bocci
Journal of the National Cancer Institute|December 30, 2015
RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch SyndromeMarco Tuccori, Kristian B Filion, Laurent Azoulay
Expert Opinion on Drug Safety|October 5, 2018
The usefulness of listening social media for pharmacovigilance purposes: a systematic reviewIrma Convertino, Sara Ferraro, Corrado Blandizzi, et al.
Vaccines|January 22, 2022
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic ReviewDaniele Focosi, Massimo Franchini, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Editorial: Traditional and innovative approaches for signal detectionMarco Tuccori, Andrew Bate, Ugo Moretti, et al.
Pageof 14